Tips from Boehringer Ingelheim
Pharmaguy interviews Patricia Alves, Social Media Community Manager, and Jaclyn Fonteyne, Social Media Specialist, at Boehringer Ingelheim, about their experience with tweetchats to inform stakeholders, build trust, and drive innovation in healthcare.
In 2013, Boehringer Ingelheim took its first steps into the world of Tweetchats, running these 'online Twitter conferences' in a number of disease areas, including atrial fibrillation, chronic obstructive pulmonary disorder (COPD) and lung cancer. Despite the regulatory challenges posed by such activities, these were all successful, both in terms of delivering value on all sides and for staying compliant.
Questions/Topics of Discussion
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.